Publications by authors named "Khyati N Shah"

7Publications

Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility.

Authors:
Angel A Ku Hsien-Ming Hu Xin Zhao Khyati N Shah Sameera Kongara Di Wu Frank McCormick Allan Balmain Sourav Bandyopadhyay

Nat Commun 2020 05 12;11(1):2375. Epub 2020 May 12.

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA.

View Article and Find Full Text PDF
May 2020

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.

Authors:
Khyati N Shah Roma Bhatt Julia Rotow Julia Rohrberg Victor Olivas Victoria E Wang Golzar Hemmati Maria M Martins Ashley Maynard Jonathan Kuhn Jacqueline Galeas Hayley J Donnella Swati Kaushik Angel Ku Sophie Dumont Gregor Krings Henry J Haringsma Liliane Robillard Andrew D Simmons Thomas C Harding Frank McCormick Andrei Goga Collin M Blakely Trever G Bivona Sourav Bandyopadhyay

Nat Med 2019 01 26;25(1):111-118. Epub 2018 Nov 26.

Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
January 2019

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.

Authors:
Hayley J Donnella James T Webber Rebecca S Levin Roman Camarda Olga Momcilovic Nora Bayani Khyati N Shah James E Korkola Kevan M Shokat Andrei Goga John D Gordan Sourav Bandyopadhyay

Nat Chem Biol 2018 08 25;14(8):768-777. Epub 2018 Jun 25.

Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.

View Article and Find Full Text PDF
August 2018

A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance.

Authors:
Hsien-Ming Hu Xin Zhao Swati Kaushik Lilliane Robillard Antoine Barthelet Kevin K Lin Khyati N Shah Andy D Simmons Mitch Raponi Thomas C Harding Sourav Bandyopadhyay

Cell Rep 2018 Apr;23(3):918-929

Bioengineering and Therapeutic Sciences, Helen Diller Family Comprehensive Cancer Center and Institute for Computational Health Sciences. University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address:

View Article and Find Full Text PDF
April 2018

Targeting Ribonucleotide Reductase M2 and NF-κB Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer.

Authors:
Khyati N Shah Elizabeth A Wilson Ritu Malla Howard L Elford Jesika S Faridi

Mol Cancer Ther 2015 Nov 2;14(11):2411-21. Epub 2015 Sep 2.

Department of Physiology and Pharmacology, Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, California.

View Article and Find Full Text PDF
November 2015

AKT-induced tamoxifen resistance is overturned by RRM2 inhibition.

Authors:
Khyati N Shah Kshama R Mehta David Peterson Marie Evangelista John C Livesey Jesika S Faridi

Mol Cancer Res 2014 Mar 20;12(3):394-407. Epub 2013 Dec 20.

Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific, 751 Brookside Road, Stockton, CA 95211.

View Article and Find Full Text PDF
March 2014

Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells.

Authors:
Khyati N Shah Jesika S Faridi

J Steroid Biochem Mol Biol 2011 Jul 21;125(3-5):219-25. Epub 2011 Mar 21.

Department of Physiology and Pharmacology, Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, 3601 Pacific Ave., Stockton, CA 95211, United States.

View Article and Find Full Text PDF
July 2011